Megakaryocytes (MKs), known for their role in platelet production, have emerged as critical players in immune responses, showcasing versatility in ...
Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...
Researchers have discovered that mouse PD-1 is significantly weaker than human PD-1, calling into question their reliability ...
A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...
A study explores the molecular dynamics of CD28.ζ-CAR and 4-1BB.ζ-CAR T cells at the immune synapse, where CAR T cells bind ...
A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer.
A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...
If approved, CagriSema will be the first fixed-dose combination of amylin and GLP-1 receptor ... cell engager (BiTE®) ...
Plasmacytoid dendritic cells (pDC) primarily function as weak antigen-presenting cells (APC), but have also been shown to ...